Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer

Ismail Kaddour-Djebbar, Vijayabaskar Lakshmikanthan, Robert B. Shirley, Yulin Ma, Ronald W Lewis, M. Vijay Kumar

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Disruption of intracellular calcium initiates multiple cell-damaging processes, such as apoptosis. In normal cells, the levels of Ca2+ are low in the mitochondria, whereas in apoptotic cells, Ca2+ increases. Mitochondria uptake Ca2+ via an inner membrane channel called the uniporter and extrude it into the cytoplasm through a Na+/Ca2+ exchanger. Overload of Ca2+ in the mitochondria in CGP-treated cells leads to its damage, thus affecting cellular function and survival. The goal of these experiments was to determine the importance of mitochondrial calcium ([Ca2+]m) in apoptosis of prostate cancer cells. Furthermore, we have examined the advantages of increasing the [Ca2+]m and treating the cells with tumor necrosis factor - related apoptosis-inducing ligand (TRAIL), a potent apoptotic agent. Our results show that, under these treatment conditions, inhibiting the Na+/Ca2+ exchanger using benzothiazepin CGP-37157 (CGP) did not induce apoptosis. However, combination of CGP and TRAIL increased the apoptotic response ∼25-fold compared with control. Increase in apoptosis followed enhanced levels of [Ca2+]m and was accompanied by pronounced mitochondrial changes characteristic of mitochondria-mediated apoptosis. Experiments with calcium ionophores showed that mere increase in cytosolic and/or mitochondrial Ca2+ was not sufficient to induce apoptosis. These results have therapeutic implications as inhibitors of Na+/Ca2+ exchanger are being used for treating some neurologic and cardiologic ailments, and TRAIL induces apoptosis preferentially in cancer cells. Furthermore, this system provides an excellent model to investigate the role of [Ca2+]m in apoptosis.

Original languageEnglish (US)
Pages (from-to)1958-1966
Number of pages9
JournalMolecular Cancer Therapeutics
Volume5
Issue number8
DOIs
StatePublished - Aug 1 2006

Fingerprint

Calcium Channel Blockers
Prostatic Neoplasms
Tumor Necrosis Factor-alpha
Apoptosis
Ligands
Mitochondria
Therapeutics
Calcium
Calcium Ionophores
Ion Channels
Nervous System
Cytoplasm

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kaddour-Djebbar, I., Lakshmikanthan, V., Shirley, R. B., Ma, Y., Lewis, R. W., & Kumar, M. V. (2006). Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. Molecular Cancer Therapeutics, 5(8), 1958-1966. https://doi.org/10.1158/1535-7163.MCT-06-0011

Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. / Kaddour-Djebbar, Ismail; Lakshmikanthan, Vijayabaskar; Shirley, Robert B.; Ma, Yulin; Lewis, Ronald W; Kumar, M. Vijay.

In: Molecular Cancer Therapeutics, Vol. 5, No. 8, 01.08.2006, p. 1958-1966.

Research output: Contribution to journalArticle

Kaddour-Djebbar, I, Lakshmikanthan, V, Shirley, RB, Ma, Y, Lewis, RW & Kumar, MV 2006, 'Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer', Molecular Cancer Therapeutics, vol. 5, no. 8, pp. 1958-1966. https://doi.org/10.1158/1535-7163.MCT-06-0011
Kaddour-Djebbar, Ismail ; Lakshmikanthan, Vijayabaskar ; Shirley, Robert B. ; Ma, Yulin ; Lewis, Ronald W ; Kumar, M. Vijay. / Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. In: Molecular Cancer Therapeutics. 2006 ; Vol. 5, No. 8. pp. 1958-1966.
@article{8370a5d6296b49ec9fd4763701c9c80e,
title = "Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer",
abstract = "Disruption of intracellular calcium initiates multiple cell-damaging processes, such as apoptosis. In normal cells, the levels of Ca2+ are low in the mitochondria, whereas in apoptotic cells, Ca2+ increases. Mitochondria uptake Ca2+ via an inner membrane channel called the uniporter and extrude it into the cytoplasm through a Na+/Ca2+ exchanger. Overload of Ca2+ in the mitochondria in CGP-treated cells leads to its damage, thus affecting cellular function and survival. The goal of these experiments was to determine the importance of mitochondrial calcium ([Ca2+]m) in apoptosis of prostate cancer cells. Furthermore, we have examined the advantages of increasing the [Ca2+]m and treating the cells with tumor necrosis factor - related apoptosis-inducing ligand (TRAIL), a potent apoptotic agent. Our results show that, under these treatment conditions, inhibiting the Na+/Ca2+ exchanger using benzothiazepin CGP-37157 (CGP) did not induce apoptosis. However, combination of CGP and TRAIL increased the apoptotic response ∼25-fold compared with control. Increase in apoptosis followed enhanced levels of [Ca2+]m and was accompanied by pronounced mitochondrial changes characteristic of mitochondria-mediated apoptosis. Experiments with calcium ionophores showed that mere increase in cytosolic and/or mitochondrial Ca2+ was not sufficient to induce apoptosis. These results have therapeutic implications as inhibitors of Na+/Ca2+ exchanger are being used for treating some neurologic and cardiologic ailments, and TRAIL induces apoptosis preferentially in cancer cells. Furthermore, this system provides an excellent model to investigate the role of [Ca2+]m in apoptosis.",
author = "Ismail Kaddour-Djebbar and Vijayabaskar Lakshmikanthan and Shirley, {Robert B.} and Yulin Ma and Lewis, {Ronald W} and Kumar, {M. Vijay}",
year = "2006",
month = "8",
day = "1",
doi = "10.1158/1535-7163.MCT-06-0011",
language = "English (US)",
volume = "5",
pages = "1958--1966",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer

AU - Kaddour-Djebbar, Ismail

AU - Lakshmikanthan, Vijayabaskar

AU - Shirley, Robert B.

AU - Ma, Yulin

AU - Lewis, Ronald W

AU - Kumar, M. Vijay

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Disruption of intracellular calcium initiates multiple cell-damaging processes, such as apoptosis. In normal cells, the levels of Ca2+ are low in the mitochondria, whereas in apoptotic cells, Ca2+ increases. Mitochondria uptake Ca2+ via an inner membrane channel called the uniporter and extrude it into the cytoplasm through a Na+/Ca2+ exchanger. Overload of Ca2+ in the mitochondria in CGP-treated cells leads to its damage, thus affecting cellular function and survival. The goal of these experiments was to determine the importance of mitochondrial calcium ([Ca2+]m) in apoptosis of prostate cancer cells. Furthermore, we have examined the advantages of increasing the [Ca2+]m and treating the cells with tumor necrosis factor - related apoptosis-inducing ligand (TRAIL), a potent apoptotic agent. Our results show that, under these treatment conditions, inhibiting the Na+/Ca2+ exchanger using benzothiazepin CGP-37157 (CGP) did not induce apoptosis. However, combination of CGP and TRAIL increased the apoptotic response ∼25-fold compared with control. Increase in apoptosis followed enhanced levels of [Ca2+]m and was accompanied by pronounced mitochondrial changes characteristic of mitochondria-mediated apoptosis. Experiments with calcium ionophores showed that mere increase in cytosolic and/or mitochondrial Ca2+ was not sufficient to induce apoptosis. These results have therapeutic implications as inhibitors of Na+/Ca2+ exchanger are being used for treating some neurologic and cardiologic ailments, and TRAIL induces apoptosis preferentially in cancer cells. Furthermore, this system provides an excellent model to investigate the role of [Ca2+]m in apoptosis.

AB - Disruption of intracellular calcium initiates multiple cell-damaging processes, such as apoptosis. In normal cells, the levels of Ca2+ are low in the mitochondria, whereas in apoptotic cells, Ca2+ increases. Mitochondria uptake Ca2+ via an inner membrane channel called the uniporter and extrude it into the cytoplasm through a Na+/Ca2+ exchanger. Overload of Ca2+ in the mitochondria in CGP-treated cells leads to its damage, thus affecting cellular function and survival. The goal of these experiments was to determine the importance of mitochondrial calcium ([Ca2+]m) in apoptosis of prostate cancer cells. Furthermore, we have examined the advantages of increasing the [Ca2+]m and treating the cells with tumor necrosis factor - related apoptosis-inducing ligand (TRAIL), a potent apoptotic agent. Our results show that, under these treatment conditions, inhibiting the Na+/Ca2+ exchanger using benzothiazepin CGP-37157 (CGP) did not induce apoptosis. However, combination of CGP and TRAIL increased the apoptotic response ∼25-fold compared with control. Increase in apoptosis followed enhanced levels of [Ca2+]m and was accompanied by pronounced mitochondrial changes characteristic of mitochondria-mediated apoptosis. Experiments with calcium ionophores showed that mere increase in cytosolic and/or mitochondrial Ca2+ was not sufficient to induce apoptosis. These results have therapeutic implications as inhibitors of Na+/Ca2+ exchanger are being used for treating some neurologic and cardiologic ailments, and TRAIL induces apoptosis preferentially in cancer cells. Furthermore, this system provides an excellent model to investigate the role of [Ca2+]m in apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=33748351614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748351614&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-06-0011

DO - 10.1158/1535-7163.MCT-06-0011

M3 - Article

VL - 5

SP - 1958

EP - 1966

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 8

ER -